Acadesine kills chronic myelogenous leukemia (CML) cells through PKC-dependent induction of autophagic cell death.
CML is an hematopoietic stem cell disease characterized by the t(9;22) (q34;q11) translocation encoding the oncoprotein p210BCR-ABL. The effect of acadesine (AICAR, 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside) a compound with known antileukemic effect on B cell chronic lymphoblastic leuke...
Guardado en:
Autores principales: | Guillaume Robert, Issam Ben Sahra, Alexandre Puissant, Pascal Colosetti, Nathalie Belhacene, Pierre Gounon, Paul Hofman, Fréderic Bost, Jill-Patrice Cassuto, Patrick Auberger |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2009
|
Materias: | |
Acceso en línea: | https://doaj.org/article/fdb62ae3eb444b589d2b79bad894e00c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Human AQP5 plays a role in the progression of chronic myelogenous leukemia (CML).
por: Young Kwang Chae, et al.
Publicado: (2008) -
Bosutinib in the management of chronic myelogenous leukemia
por: Keller-von Amsberg G, et al.
Publicado: (2013) -
Resistant mutations in CML and Ph+ALL – role of ponatinib
por: Miller GD, et al.
Publicado: (2014) -
Kinetics of PKCε activating and inhibiting llama single chain antibodies and their effect on PKCε translocation in HeLa cells.
por: Milla Summanen, et al.
Publicado: (2012) -
The lysophospholipase D enzyme Gdpd3 is required to maintain chronic myelogenous leukaemia stem cells
por: Kazuhito Naka, et al.
Publicado: (2020)